Skip to content

Vaniprevir

C38H55N5O9S — CID 122173813

💊View drug profile → vaniprevir

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC(1R,21S,26S)-21-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-ethylcyclopropyl]-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.14,7.06,11]heptacosa-6(11),7,9-triene-26-carboxamide
SMILESCC[C@@H]1C[C@]1(NC(=O)[C@@H]1[C@H]2CCN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1
InChIInChI=1S/C38H55N5O9S/c1-7-25-19-38(25,33(46)41-53(49,50)26-14-15-26)40-31(44)29-28-16-18-43(29)32(45)30(36(2,3)4)39-34(47)51-22-37(5,6)17-9-8-11-23-12-10-13-24-20-42(21-27(23)24)35(48)52-28/h10,12-13,25-26,28-30H,7-9,11,14-22H2,1-6H3,(H,39,47)(H,40,44)(H,41,46)/t25-,28-,29+,30-,38-/m1/s1
InChIKeyKYLWQAGGDVJPKM-ZBVFNZHQSA-N
MW757.95 g/mol
LogP3.90
Rot. Bonds6

About Vaniprevir

Vaniprevir (PubChem CID 122173813) has the molecular formula C38H55N5O9S and a molecular weight of 757.95 g/mol. Its IUPAC name is (1R,21S,26S)-21-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-ethylcyclopropyl]-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.14,7.06,11]heptacosa-6(11),7,9-triene-26-carboxamide.

Molecular Properties

Compound NameVaniprevir
PubChem CID122173813
Molecular FormulaC38H55N5O9S
Molecular Weight757.95 g/mol
Exact Mass757.37
IUPAC Name(1R,21S,26S)-21-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-ethylcyclopropyl]-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.14,7.06,11]heptacosa-6(11),7,9-triene-26-carboxamide
SMILESCC[C@@H]1C[C@]1(NC(=O)[C@@H]1[C@H]2CCN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1
InChIInChI=1S/C38H55N5O9S/c1-7-25-19-38(25,33(46)41-53(49,50)26-14-15-26)40-31(44)29-28-16-18-43(29)32(45)30(36(2,3)4)39-34(47)51-22-37(5,6)17-9-8-11-23-12-10-13-24-20-42(21-27(23)24)35(48)52-28/h10,12-13,25-26,28-30H,7-9,11,14-22H2,1-6H3,(H,39,47)(H,40,44)(H,41,46)/t25-,28-,29+,30-,38-/m1/s1
InChIKeyKYLWQAGGDVJPKM-ZBVFNZHQSA-N
XLogP3.90
TPSA180.52 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds6
Heavy Atoms53
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500757.95
LogP ≤ 53.90
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Analyze Vaniprevir with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of Vaniprevir?
The IUPAC name of Vaniprevir (CID 122173813) is (1R,21S,26S)-21-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-ethylcyclopropyl]-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.14,7.06,11]heptacosa-6(11),7,9-triene-26-carboxamide.
What is the SMILES notation for Vaniprevir?
The canonical SMILES for Vaniprevir is CC[C@@H]1C[C@]1(NC(=O)[C@@H]1[C@H]2CCN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1.
What is the InChIKey of Vaniprevir?
The InChIKey is KYLWQAGGDVJPKM-ZBVFNZHQSA-N. The full InChI is InChI=1S/C38H55N5O9S/c1-7-25-19-38(25,33(46)41-53(49,50)26-14-15-26)40-31(44)29-28-16-18-43(29)32(45)30(36(2,3)4)39-34(47)51-22-37(5,6)17-9-8-11-23-12-10-13-24-20-42(21-27(23)24)35(48)52-28/h10,12-13,25-26,28-30H,7-9,11,14-22H2,1-6H3,(H,39,47)(H,40,44)(H,41,46)/t25-,28-,29+,30-,38-/m1/s1.
What are the key properties of Vaniprevir?
Vaniprevir has a molecular weight of 757.95 g/mol, XLogP of 3.90, 6 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for Vaniprevir is sourced from PubChem (CID 122173813), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules: M · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.